{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T02:06:58Z","timestamp":1794276418553,"version":"4.9.0"},"reference-count":77,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T00:00:00Z","timestamp":1780099200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T00:00:00Z","timestamp":1780099200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100004704","name":"National Research Council of Thailand","doi-asserted-by":"publisher","award":["Grant No N41A640207"],"award-info":[{"award-number":["Grant No N41A640207"]}],"id":[{"id":"10.13039\/501100004704","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004704","name":"National Research Council of Thailand","doi-asserted-by":"crossref","award":["Grant No. N42A670596"],"award-info":[{"award-number":["Grant No. N42A670596"]}],"id":[{"id":"10.13039\/501100004704","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Physiol Biochem"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s13105-026-01193-z","type":"journal-article","created":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T06:57:47Z","timestamp":1780124267000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Therapeutic effects of chitooligosaccharide-epigallocatechin gallate conjugate on NAFLD: impact on gut-liver axis, lipid metabolism, and inflammation in rats fed a high-fat diet"],"prefix":"10.1007","volume":"82","author":[{"given":"Sirikul","family":"Mueangaun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kanokrada","family":"Tonphu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natcha","family":"Lerkdumnernkit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jirakhamon","family":"Sengking","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiraporn","family":"Tocharus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soottawat","family":"Benjakul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chainarong","family":"Tocharus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,30]]},"reference":[{"key":"1193_CR1","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/nrgastro.2017.109","volume":"15","author":"Z Younossi","year":"2018","unstructured":"Younossi Z, Anstee QM, Marietti M, Hardy T, Henry L et al (2018) Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention. Nat Rev Gastroenterol Hepatol 15:11\u201320. https:\/\/doi.org\/10.1038\/nrgastro.2017.109","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"1193_CR2","doi-asserted-by":"publisher","first-page":"1517174","DOI":"10.3389\/fphar.2025.1517174","volume":"16","author":"M Cheng","year":"2025","unstructured":"Cheng M, Ding F, Li L, Dai C, Sun X et al (2025) Exploring the role of curcumin in mitigating oxidative stress to alleviate lipid metabolism disorders. Front Pharmacol 16:1517174. https:\/\/doi.org\/10.3389\/fphar.2025.1517174","journal-title":"Front Pharmacol"},{"key":"1193_CR3","doi-asserted-by":"publisher","first-page":"1323261","DOI":"10.3389\/fcimb.2024.1323261","volume":"14","author":"T Cai","year":"2024","unstructured":"Cai T, Song X, Xu X, Dong L, Liang S et al (2024) Effects of plant natural products on metabolic-associated fatty liver disease and the underlying mechanisms: a narrative review with a focus on the modulation of the gut microbiota. Front Cell Infect Microbiol 14:1323261. https:\/\/doi.org\/10.3389\/fcimb.2024.1323261","journal-title":"Front Cell Infect Microbiol"},{"key":"1193_CR4","first-page":"167","volume":"11","author":"F Nassir","year":"2015","unstructured":"Nassir F, Rector RS, Hammoud GM, Ibdah JA (2015) Pathogenesis and prevention of hepatic steatosis. Gastroenterol Hepatol 11:167\u2013175","journal-title":"Gastroenterol Hepatol"},{"key":"1193_CR5","doi-asserted-by":"publisher","first-page":"15718","DOI":"10.1073\/pnas.0407076101","volume":"101","author":"F B\u00e4ckhed","year":"2004","unstructured":"B\u00e4ckhed F, Ding H, Wang T, Hooper LV, Koh GY et al (2004) The gut microbiota as an environmental factor that regulates fat storage. Proc Natl Acad Sci USA 101:15718\u201315723. https:\/\/doi.org\/10.1073\/pnas.0407076101","journal-title":"Proc Natl Acad Sci USA"},{"key":"1193_CR6","doi-asserted-by":"publisher","first-page":"175788","DOI":"10.1016\/j.ejphar.2023.175788","volume":"951","author":"Y Huang","year":"2023","unstructured":"Huang Y, Wang C, Wang M, Xiong T, Song X et al (2023) Oroxin B improves metabolic-associated fatty liver disease by alleviating gut microbiota dysbiosis in a high-fat diet-induced rat model. Eur J Pharmacol 951:175788. https:\/\/doi.org\/10.1016\/j.ejphar.2023.175788","journal-title":"Eur J Pharmacol"},{"key":"1193_CR7","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1093\/qjmed\/hcp158","volume":"103","author":"JK Dowman","year":"2010","unstructured":"Dowman JK, Tomlinson JW, Newsome PN (2010) Pathogenesis of non-alcoholic fatty liver disease. QJM 103:71\u201383. https:\/\/doi.org\/10.1093\/qjmed\/hcp158","journal-title":"QJM"},{"key":"1193_CR8","doi-asserted-by":"publisher","first-page":"3898","DOI":"10.1039\/D0FO02736G","volume":"12","author":"J Li","year":"2021","unstructured":"Li J, Wang T, Liu P, Yang F, Wang X et al (2021) Hesperetin ameliorates hepatic oxidative stress and inflammation via the PI3K\/AKT-Nrf2-ARE pathway in oleic acid-induced HepG2 cells and a rat model of high-fat diet-induced NAFLD. Food Funct 12:3898\u20133918. https:\/\/doi.org\/10.1039\/D0FO02736G","journal-title":"Food Funct"},{"key":"1193_CR9","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1007\/s12072-021-10138-1","volume":"15","author":"Y Xu","year":"2021","unstructured":"Xu Y, Wang N, Tan HY, Li S, Zhang C et al (2021) Gut-liver axis modulation of Panax notoginseng saponins in nonalcoholic fatty liver disease. Hepatol Int 15:350\u2013365. https:\/\/doi.org\/10.1007\/s12072-021-10138-1","journal-title":"Hepatol Int"},{"key":"1193_CR10","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.ijbiomac.2019.02.097","volume":"130","author":"J Wu","year":"2019","unstructured":"Wu J, Shao H, Zhang J, Ying Y, Cheng Y et al (2019) Mussel polysaccharide \u03b1-D-glucan (MP-A) protects against non-alcoholic fatty liver disease via maintaining the homeostasis of gut microbiota and regulating related gut-liver axis signaling pathways. Int J Biol Macromol 130:68\u201378. https:\/\/doi.org\/10.1016\/j.ijbiomac.2019.02.097","journal-title":"Int J Biol Macromol"},{"key":"1193_CR11","doi-asserted-by":"publisher","first-page":"2555","DOI":"10.1038\/s41467022-29968-0","volume":"13","author":"R Cheng","year":"2022","unstructured":"Cheng R, Wang L, Le S, Yang Y, Zhao C et al (2022) A randomized controlled trial for response of microbiome network to exercise and diet intervention in patients with nonalcoholic fatty liver disease. Nat Commun 13:2555. https:\/\/doi.org\/10.1038\/s41467022-29968-0","journal-title":"Nat Commun"},{"key":"1193_CR12","doi-asserted-by":"publisher","first-page":"9420016","DOI":"10.26599\/FMH.2024.9420016","volume":"1","author":"Y-F Liu","year":"2024","unstructured":"Liu Y-F, Ling N, Zhang B, Chen C, Mo X-N et al (2024) Flavonoid-Rich mulberry leaf extract modulate lipid metabolism, antioxidant capacity, and gut microbiota in high-fat diet-induced obesity: potential roles of FGF21 and SOCS2. Food Med Homology 1:9420016. https:\/\/doi.org\/10.26599\/FMH.2024.9420016","journal-title":"Food Med Homology"},{"key":"1193_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jfutfo.2026.02.009","author":"Q Fang","year":"2026","unstructured":"Fang Q, Qin C, Peng Y, Xu Z, Li D et al (2026) Pu-erh tea regulated chronic low-grade inflammation and multi-organ interaction dysfunction via the gut microbiota-SCFAs-mitochondria axis. J Future Foods. https:\/\/doi.org\/10.1016\/j.jfutfo.2026.02.009","journal-title":"J Future Foods"},{"key":"1193_CR14","doi-asserted-by":"publisher","first-page":"2703","DOI":"10.26599\/FSHW.2022.9250218","volume":"13","author":"L Li","year":"2024","unstructured":"Li L, Yang S, Liang X, Liu Y, Xu H et al (2024) Saikosaponin D improves nonalcoholic fatty liver disease via gut microbiota-bile acid metabolism pathway. Food Sci Hum Wellness 13:2703\u20132717. https:\/\/doi.org\/10.26599\/FSHW.2022.9250218","journal-title":"Food Sci Hum Wellness"},{"key":"1193_CR15","doi-asserted-by":"publisher","first-page":"563","DOI":"10.3389\/fmicb.2017.00563","volume":"8","author":"DK Dahiya","year":"2017","unstructured":"Dahiya DK, Renuka, Puniya M, Shandilya UK, Dhewa T et al (2017) Gut microbiota modulation and its relationship with obesity using prebiotic fibers and probiotics: a review. Front Microbiol 8:563. https:\/\/doi.org\/10.3389\/fmicb.2017.00563","journal-title":"Front Microbiol"},{"key":"1193_CR16","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.3390\/md8051482","volume":"8","author":"BB Aam","year":"2010","unstructured":"Aam BB, Heggset EB, Norberg AL, S\u00f8rlie M, V\u00e5rum KM et al (2010) Production of chitooligosaccharides and their potential applications in medicine. Mar Drugs 8:1482\u20131517. https:\/\/doi.org\/10.3390\/md8051482","journal-title":"Mar Drugs"},{"key":"1193_CR17","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.carbpol.2017.12.067","volume":"184","author":"F Liaqat","year":"2018","unstructured":"Liaqat F, Eltem R (2018) Chitooligosaccharides and their biological activities: A comprehensive review. Carbohydr Polym 184:243\u2013259. https:\/\/doi.org\/10.1016\/j.carbpol.2017.12.067","journal-title":"Carbohydr Polym"},{"key":"1193_CR18","doi-asserted-by":"publisher","first-page":"654913","DOI":"10.1155\/2014\/654913","volume":"2014","author":"G Lodhi","year":"2014","unstructured":"Lodhi G, Kim YS, Hwang JW, Kim SK, Jeon YJ et al (2014) Chitooligosaccharide and its derivatives: preparation and biological applications. BioMed Res Int 2014:654913. https:\/\/doi.org\/10.1155\/2014\/654913","journal-title":"BioMed Res Int"},{"key":"1193_CR19","doi-asserted-by":"publisher","first-page":"391","DOI":"10.3390\/md17070391","volume":"17","author":"M Qian","year":"2019","unstructured":"Qian M, Lyu Q, Liu Y, Hu H, Wang S et al (2019) Chitosan oligosaccharide ameliorates nonalcoholic fatty liver disease (NAFLD) in diet-induced obese mice. Mar Drugs 17:391. https:\/\/doi.org\/10.3390\/md17070391","journal-title":"Mar Drugs"},{"key":"1193_CR20","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1002\/lt.20348","volume":"11","author":"RN Fiorini","year":"2005","unstructured":"Fiorini RN, Donovan JL, Rodwell D, Evans Z, Cheng G et al (2005) Short-term administration of (-)-epigallocatechin gallate reduces hepatic steatosis and protects against warm hepatic ischemia\/reperfusion injury in steatotic mice. Liver Transpl 11:298\u2013308. https:\/\/doi.org\/10.1002\/lt.20348","journal-title":"Liver Transpl"},{"key":"1193_CR21","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1017\/S0007114511003758","volume":"107","author":"T Goto","year":"2012","unstructured":"Goto T, Saito Y, Morikawa K, Kanamaru Y, Nagaoka S (2012) Epigallocatechin gallate changes mRNA expression level of genes involved in cholesterol metabolism in hepatocytes. Br J Nutr 107:769\u2013773. https:\/\/doi.org\/10.1017\/S0007114511003758","journal-title":"Br J Nutr"},{"key":"1193_CR22","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.carbpol.2016.08.056","volume":"155","author":"MJ Moreno-V\u00e1squez","year":"2017","unstructured":"Moreno-V\u00e1squez MJ, Valenzuela-Buitimea EL, Plascencia-Jatomea M, Encinas-Encinas JC, Rodr\u00edguez-F\u00e9lix F et al (2017) Functionalization of chitosan by a free radical reaction: Characterization, antioxidant and antibacterial potential. Carbohydr Polym 155:117\u2013127. https:\/\/doi.org\/10.1016\/j.carbpol.2016.08.056","journal-title":"Carbohydr Polym"},{"key":"1193_CR23","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1038\/ijo.2011.136","volume":"36","author":"M Friedrich","year":"2012","unstructured":"Friedrich M, Petzke KJ, Raederstorff D, Wolfram S, Klaus S (2012) Acute effects of epigallocatechin gallate from green tea on oxidation and tissue incorporation of dietary lipids in mice fed a high-fat diet. Int J Obes 36:735\u2013743. https:\/\/doi.org\/10.1038\/ijo.2011.136","journal-title":"Int J Obes"},{"key":"1193_CR24","doi-asserted-by":"publisher","first-page":"920128","DOI":"10.1155\/2013\/920128","volume":"2013","author":"JJ Kim","year":"2013","unstructured":"Kim JJ, Tan Y, Xiao L, Sun YL, Qu X (2013) Green tea polyphenol epigallocatechin-3-gallate enhance glycogen synthesis and inhibit lipogenesis in hepatocytes. Biomed Res Int 2013:920128. https:\/\/doi.org\/10.1155\/2013\/920128","journal-title":"Biomed Res Int"},{"key":"1193_CR25","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1111\/2049-632X.12001","volume":"67","author":"Y Cai","year":"2013","unstructured":"Cai Y, Kurita-Ochiai T, Hashizume T, Yamamoto M (2013) Green tea epigallocatechin-3-gallate attenuates Porphyromonas gingivalis-induced atherosclerosis. Pathog Dis 67:76\u201383. https:\/\/doi.org\/10.1111\/2049-632X.12001","journal-title":"Pathog Dis"},{"key":"1193_CR26","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.jnutbio.2015.10.003","volume":"28","author":"D Liu","year":"2016","unstructured":"Liu D, Perkins JT, Hennig B (2016) EGCG prevents PCB-126-induced endothelial cell inflammation via epigenetic modifications of NF-\u03baB target genes in human endothelial cells. J Nutr Biochem 28:164\u2013170. https:\/\/doi.org\/10.1016\/j.jnutbio.2015.10.003","journal-title":"J Nutr Biochem"},{"key":"1193_CR27","doi-asserted-by":"publisher","first-page":"213","DOI":"10.3177\/jnsv.60.213","volume":"60","author":"T Unno","year":"2014","unstructured":"Unno T, Sakuma M, Mitsuhashi S (2014) Effect of dietary supplementation of (-)-epigallocatechin gallate on gut microbiota and biomarkers of colonic fermentation in rats. J Nutr Sci Vitaminol 60:213\u2013219. https:\/\/doi.org\/10.3177\/jnsv.60.213","journal-title":"J Nutr Sci Vitaminol"},{"key":"1193_CR28","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.3390\/molecules21101305","volume":"21","author":"T Suzuki","year":"2016","unstructured":"Suzuki T, Pervin M, Goto S, Isemura M, Nakamura Y (2016) Beneficial effects of tea and the green tea catechin epigallocatechin-3-gallate on obesity. Molecules 21:1305. https:\/\/doi.org\/10.3390\/molecules21101305","journal-title":"Molecules"},{"key":"1193_CR29","doi-asserted-by":"publisher","first-page":"134456","DOI":"10.1016\/j.foodchem.2022.134456","volume":"403","author":"A Mittal","year":"2023","unstructured":"Mittal A, Singh A, Benjakul S (2023) \u03b1-amylase inhibitory activity of chitooligosaccharide from shrimp shell chitosan and its epigallocatechin gallate conjugate: kinetics, fluorescence quenching and structure-activity relationship. Food Chem 403:134456. https:\/\/doi.org\/10.1016\/j.foodchem.2022.134456","journal-title":"Food Chem"},{"key":"1193_CR30","doi-asserted-by":"publisher","first-page":"920","DOI":"10.3390\/foods11070920","volume":"11","author":"A Mittal","year":"2022","unstructured":"Mittal A, Singh A, Zhang B, Visessanguan W, Benjakul S (2022) Chitooligosaccharide conjugates prepared using several phenolic compounds via Ascorbic Acid\/H2O2 free radical grafting: characteristics, antioxidant, antidiabetic, and antimicrobial activities. Foods 11:920. https:\/\/doi.org\/10.3390\/foods11070920","journal-title":"Foods"},{"key":"1193_CR31","doi-asserted-by":"publisher","first-page":"19405","DOI":"10.1016\/j.carbpol.2022.119405","volume":"288","author":"P Sutthasupha","year":"2022","unstructured":"Sutthasupha P, Promsan S, Thongnak L, Pengrattanachot N, Phengpol N et al (2022) Chitosan oligosaccharide mitigates kidney injury in prediabetic rats by improving intestinal barrier and renal autophagy. Carbohydr Polym 288:19405. https:\/\/doi.org\/10.1016\/j.carbpol.2022.119405","journal-title":"Carbohydr Polym"},{"key":"1193_CR32","doi-asserted-by":"publisher","first-page":"e23279","DOI":"10.1002\/jbt.23279","volume":"37","author":"N Wikan","year":"2023","unstructured":"Wikan N, Tocharus J, Oka C, Sivasinprasasn S, Chaichompoo W et al (2023) The capsaicinoid nonivamide suppresses the inflammatory response and attenuates the progression of steatosis in a NAFLD-rat model. J Biochem Mol Toxicol 37:e23279. https:\/\/doi.org\/10.1002\/jbt.23279","journal-title":"J Biochem Mol Toxicol"},{"key":"1193_CR33","doi-asserted-by":"publisher","first-page":"111316","DOI":"10.1016\/j.cbi.2024.111316","volume":"406","author":"K Tonphu","year":"2025","unstructured":"Tonphu K, Mueangaun S, Lerkdumnernkit N, Sengking J, Tocharus J et al (2025) Chitooligosaccharide-epigallocatechin gallate conjugate ameliorates lipid accumulation and promotes browning of white adipose tissue in high fat diet fed rats. Chem Biol Interact 406:111316. https:\/\/doi.org\/10.1016\/j.cbi.2024.111316","journal-title":"Chem Biol Interact"},{"key":"1193_CR34","doi-asserted-by":"publisher","first-page":"113987","DOI":"10.1016\/j.fct.2023.113987","volume":"180","author":"N Wikan","year":"2023","unstructured":"Wikan N, Tocharus J, Oka C, Sivasinprasasn S, Chaichompoo W et al (2023) Pelargonic acid vanillylamide alleviates hepatic autophagy and ER stress in hepatic steatosis model. Food Chem Toxicol 180:113987. https:\/\/doi.org\/10.1016\/j.fct.2023.113987","journal-title":"Food Chem Toxicol"},{"key":"1193_CR35","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1139\/o59-099","volume":"37","author":"EG Bligh","year":"1959","unstructured":"Bligh EG, Dyer WJ (1959) A rapid method of total lipid extraction and purification. Can J Biochem Physiol 37:911\u2013917. https:\/\/doi.org\/10.1139\/o59-099","journal-title":"Can J Biochem Physiol"},{"key":"1193_CR36","doi-asserted-by":"publisher","first-page":"e1375","DOI":"10.21769\/bioprotoc.1375","volume":"5","author":"D Kraus","year":"2015","unstructured":"Kraus D, Yang Q, Kahn BB (2015) Lipid extraction from mouse feces. Bio Protoc 5:e1375. https:\/\/doi.org\/10.21769\/bioprotoc.1375","journal-title":"Bio Protoc"},{"key":"1193_CR37","doi-asserted-by":"publisher","first-page":"1078447","DOI":"10.3389\/fcimb.2023.1078447","volume":"13","author":"G Tian","year":"2023","unstructured":"Tian G, Wang W, Xia E, Chen W, Zhang S (2023) Dendrobium officinale alleviates high-fat diet-induced nonalcoholic steatohepatitis by modulating gut microbiota. Front Cell Infect Microbiol 13:1078447. https:\/\/doi.org\/10.3389\/fcimb.2023.1078447","journal-title":"Front Cell Infect Microbiol"},{"key":"1193_CR38","doi-asserted-by":"publisher","first-page":"2957","DOI":"10.1093\/bioinformatics\/btr507","volume":"27","author":"T Mago\u010d","year":"2011","unstructured":"Mago\u010d T, Salzberg SL (2011) FLASH: fast length adjustment of short reads to improve genome assemblies. Bioinformatics 27:2957\u20132963. https:\/\/doi.org\/10.1093\/bioinformatics\/btr507","journal-title":"Bioinformatics"},{"key":"1193_CR39","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/nmeth.2276","volume":"10","author":"NA Bokulich","year":"2013","unstructured":"Bokulich NA, Subramanian S, Faith JJ, Gevers D, Gordon JI et al (2013) Quality-filtering vastly improves diversity estimates from Illumina amplicon sequencing. Nat Methods 10:57\u201359. https:\/\/doi.org\/10.1038\/nmeth.2276","journal-title":"Nat Methods"},{"key":"1193_CR40","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1002\/hep.20701","volume":"41","author":"DE Kleiner","year":"2005","unstructured":"Kleiner DE, Brunt EM, Van Natta M, Behling C, Contos MJ et al (2005) Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 41:1313\u20131321. https:\/\/doi.org\/10.1002\/hep.20701","journal-title":"Hepatology"},{"key":"1193_CR41","doi-asserted-by":"publisher","first-page":"2467","DOI":"10.1111\/j.1572-0241.1999.01377.x","volume":"94","author":"EM Brunt","year":"1999","unstructured":"Brunt EM, Janney CG, Di Bisceglie AM, Neuschwander-Tetri BA, Bacon BR (1999) Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am J Gastroenterol 94:2467\u20132474. https:\/\/doi.org\/10.1111\/j.1572-0241.1999.01377.x","journal-title":"Am J Gastroenterol"},{"key":"1193_CR42","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1002\/hep.24127","volume":"53","author":"EM Brunt","year":"2011","unstructured":"Brunt EM, Kleiner DE, Wilson LA, Belt P, Neuschwander-Tetri BA (2011) Nonalcoholic fatty liver disease (NAFLD) activity score and the histopathologic diagnosis in NAFLD: distinct clinicopathologic meanings. Hepatology 53:810\u2013820. https:\/\/doi.org\/10.1002\/hep.24127","journal-title":"Hepatology"},{"key":"1193_CR43","doi-asserted-by":"publisher","first-page":"G194","DOI":"10.1152\/ajpgi.00413.2005","volume":"290","author":"MW Bradbury","year":"2006","unstructured":"Bradbury MW (2006) Lipid metabolism and liver inflammation. I. Hepatic fatty acid uptake: possible role in steatosis. Am J Physiol Gastrointest Liver Physiol 290:G194\u2013198. https:\/\/doi.org\/10.1152\/ajpgi.00413.2005","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"1193_CR44","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1016\/j.jhep.2018.04.006","volume":"69","author":"L Zhao","year":"2018","unstructured":"Zhao L, Zhang C, Luo X, Wang P, Zhou W et al (2018) CD36 palmitoylation disrupts free fatty acid metabolism and promotes tissue inflammation in non-alcoholic steatohepatitis. J Hepatol 69:705\u2013717. https:\/\/doi.org\/10.1016\/j.jhep.2018.04.006","journal-title":"J Hepatol"},{"key":"1193_CR45","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1007\/s00535-013-0758-5","volume":"48","author":"Y Kawano","year":"2013","unstructured":"Kawano Y, Cohen DE (2013) Mechanisms of hepatic triglyceride accumulation in non-alcoholic fatty liver disease. J Gastroenterol 48:434\u2013441. https:\/\/doi.org\/10.1007\/s00535-013-0758-5","journal-title":"J Gastroenterol"},{"key":"1193_CR46","doi-asserted-by":"publisher","first-page":"G1281","DOI":"10.1152\/ajpgi.00074.2008","volume":"294","author":"D Greco","year":"2008","unstructured":"Greco D, Kotronen A, Westerbacka J, Puig O, Arkkila P et al (2008) Gene expression in human NAFLD. Am J Physiol Gastrointest Liver Physiol 294:G1281\u20131287. https:\/\/doi.org\/10.1152\/ajpgi.00074.2008","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"1193_CR47","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1111\/eci.12192","volume":"44","author":"C Garc\u00eda-Monz\u00f3n","year":"2014","unstructured":"Garc\u00eda-Monz\u00f3n C, Lo Iacono O, Crespo J, Romero-G\u00f3mez M, Garc\u00eda-Samaniego J et al (2014) Increased soluble CD36 is linked to advanced steatosis in nonalcoholic fatty liver disease. Eur J Clin Invest 44:65\u201373. https:\/\/doi.org\/10.1111\/eci.12192","journal-title":"Eur J Clin Invest"},{"key":"1193_CR48","doi-asserted-by":"publisher","first-page":"3204","DOI":"10.1021\/acs.est.1c07182","volume":"56","author":"Z Sun","year":"2022","unstructured":"Sun Z, Tang Z, Yang X, Liu QS, Zhang J et al (2022) 3-tert-Butyl-4-hydroxyanisole impairs hepatic lipid metabolism in male mice fed with a high-fat diet. Environ Sci Technol 56:3204\u20133213. https:\/\/doi.org\/10.1021\/acs.est.1c07182","journal-title":"Environ Sci Technol"},{"key":"1193_CR49","first-page":"507","volume":"21","author":"M Kohjima","year":"2008","unstructured":"Kohjima M, Higuchi N, Kato M, Kotoh K, Yoshimoto T et al (2008) SREBP-1c, regulated by the insulin and AMPK signaling pathways, plays a role in nonalcoholic fatty liver disease. Int J Mol Med 21:507\u2013511","journal-title":"Int J Mol Med"},{"key":"1193_CR50","doi-asserted-by":"publisher","first-page":"3313","DOI":"10.1007\/s00018-018-2860-6","volume":"75","author":"CH Ipsen","year":"2018","unstructured":"Ipsen CH, Lykkesfeldt J, Tveden-Nyborg P (2018) Molecular mechanisms of hepatic lipid accumulation in non-alcoholic fatty liver disease. Cell Mol Life Sci 75:3313\u20133327. https:\/\/doi.org\/10.1007\/s00018-018-2860-6","journal-title":"Cell Mol Life Sci"},{"key":"1193_CR51","doi-asserted-by":"publisher","first-page":"221","DOI":"10.2147\/CEG.S62831","volume":"7","author":"A Berlanga","year":"2014","unstructured":"Berlanga A, Guiu-Jurado E, Porras JA, Auguet T (2014) Molecular pathways in non-alcoholic fatty liver disease. Clin Exp Gastroenterol 7:221\u2013239. https:\/\/doi.org\/10.2147\/CEG.S62831","journal-title":"Clin Exp Gastroenterol"},{"key":"1193_CR52","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.jceh.2016.09.001","volume":"6","author":"JS Wooten","year":"2016","unstructured":"Wooten JS, Nick TN, Seija A, Poole KE, Stout KB (2016) High-fructose intake impairs the hepatic hypolipidemic effects of a high-fat fish-oil diet in C57BL\/6 mice. J Clin Exp Hepatol 6:265\u2013274. https:\/\/doi.org\/10.1016\/j.jceh.2016.09.001","journal-title":"J Clin Exp Hepatol"},{"key":"1193_CR53","doi-asserted-by":"publisher","first-page":"198","DOI":"10.4093\/dmj.2015.39.3.198","volume":"39","author":"KY Hur","year":"2015","unstructured":"Hur KY, Lee MS (2015) Gut microbiota and metabolic disorders. Diabetes Metab J 39:198\u2013203. https:\/\/doi.org\/10.4093\/dmj.2015.39.3.198","journal-title":"Diabetes Metab J"},{"key":"1193_CR54","doi-asserted-by":"publisher","first-page":"8603","DOI":"10.1111\/jcmm.15489","volume":"24","author":"T Yu","year":"2020","unstructured":"Yu T, Wang Y, Chen X, Xiong W, Tang Y et al (2020) Spirulina platensis alleviates chronic inflammation with modulation of gut microbiota and intestinal permeability in rats fed a high-fat diet. J Cell Mol Med 24:8603\u20138613. https:\/\/doi.org\/10.1111\/jcmm.15489","journal-title":"J Cell Mol Med"},{"key":"1193_CR55","doi-asserted-by":"publisher","first-page":"719967","DOI":"10.3389\/fmicb.2021.719967","volume":"12","author":"M Yang","year":"2021","unstructured":"Yang M, Yin Y, Wang F, Zhang H, Ma X et al (2021) Supplementation with Lycium barbarum polysaccharides reduce obesity in high-fat diet-fed mice by modulation of gut microbiota. Front Microbiol 12:719967. https:\/\/doi.org\/10.3389\/fmicb.2021.719967","journal-title":"Front Microbiol"},{"key":"1193_CR56","doi-asserted-by":"publisher","first-page":"11070","DOI":"10.1073\/pnas.0504978102","volume":"102","author":"RE Ley","year":"2005","unstructured":"Ley RE, B\u00e4ckhed F, Turnbaugh P, Lozupone CA, Knight RD et al (2005) Obesity alters gut microbial ecology. Proc Natl Acad Sci USA 102:11070\u201311075. https:\/\/doi.org\/10.1073\/pnas.0504978102","journal-title":"Proc Natl Acad Sci USA"},{"key":"1193_CR57","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1038\/4441022a","volume":"444","author":"RE Ley","year":"2006","unstructured":"Ley RE, Turnbaugh PJ, Klein S, Gordon JI (2006) Microbial ecology: human gut microbes associated with obesity. Nature 444:1022\u20131023. https:\/\/doi.org\/10.1038\/4441022a","journal-title":"Nature"},{"key":"1193_CR58","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1016\/j.tibtech.2015.06.011","volume":"33","author":"NR Shin","year":"2015","unstructured":"Shin NR, Whon TW, Bae JW (2015) Proteobacteria: microbial signature of dysbiosis in gut microbiota. Trends Biotechnol 33:496\u2013503. https:\/\/doi.org\/10.1016\/j.tibtech.2015.06.011","journal-title":"Trends Biotechnol"},{"key":"1193_CR59","doi-asserted-by":"publisher","first-page":"16733","DOI":"10.3390\/ijms242316733","volume":"24","author":"X Zhu","year":"2023","unstructured":"Zhu X, Cai J, Wang Y, Liu X, Chen X et al (2023) A high-fat diet increases the characteristics of gut microbial composition and the intestinal damage associated with non-alcoholic fatty liver disease. Int J Mol Sci 24:16733. https:\/\/doi.org\/10.3390\/ijms242316733","journal-title":"Int J Mol Sci"},{"key":"1193_CR60","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/s12986-020-00516-1","volume":"17","author":"Q Zhou","year":"2020","unstructured":"Zhou Q, Zhang Y, Wang X, Yang R, Zhu X et al (2020) Gut bacteria Akkermansia is associated with reduced risk of obesity: evidence from the American Gut Project. Nutr Metab 17:90. https:\/\/doi.org\/10.1186\/s12986-020-00516-1","journal-title":"Nutr Metab"},{"key":"1193_CR61","doi-asserted-by":"publisher","first-page":"9066","DOI":"10.1073\/pnas.1219451110","volume":"110","author":"A Everard","year":"2013","unstructured":"Everard A, Belzer C, Geurts L, Ouwerkerk JP, Druart C et al (2013) Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity. Proc Natl Acad Sci USA 110:9066\u20139071. https:\/\/doi.org\/10.1073\/pnas.1219451110","journal-title":"Proc Natl Acad Sci USA"},{"key":"1193_CR62","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1152\/physiolgenomics.00114.2017","volume":"50","author":"N Jiao","year":"2018","unstructured":"Jiao N, Baker SS, Nugent CA, Tsompana M, Cai L et al (2018) Gut microbiome may contribute to insulin resistance and systemic inflammation in obese rodents: a meta-analysis. Physiol Genomics 50:244\u2013254. https:\/\/doi.org\/10.1152\/physiolgenomics.00114.2017","journal-title":"Physiol Genomics"},{"key":"1193_CR63","doi-asserted-by":"publisher","first-page":"12014","DOI":"10.1021\/acs.jafc.2c04817","volume":"70","author":"J Sun","year":"2022","unstructured":"Sun J, Fan J, Li T, Yan X, Jiang Y (2022) Nuciferine protects against high-fat diet-induced hepatic steatosis via modulation of gut microbiota and bile acid metabolism in rats. J Agric Food Chem 70:12014\u201312028. https:\/\/doi.org\/10.1021\/acs.jafc.2c04817","journal-title":"J Agric Food Chem"},{"key":"1193_CR64","doi-asserted-by":"publisher","first-page":"e0126976","DOI":"10.1371\/journal.pone.0126976","volume":"10","author":"A Moya-P\u00e9rez","year":"2015","unstructured":"Moya-P\u00e9rez A, Neef A, Sanz Y (2015) Bifidobacterium pseudocatenulatum CECT 7765 reduces obesity-associated inflammation by restoring the lymphocyte-macrophage balance and gut microbiota structure in high-fat diet-fed mice. PLoS ONE 10:e0126976. https:\/\/doi.org\/10.1371\/journal.pone.0126976","journal-title":"PLoS ONE"},{"key":"1193_CR65","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1136\/gutjnl-2011-300705","volume":"62","author":"EF Murphy","year":"2013","unstructured":"Murphy EF, Cotter PD, Hogan A, O\u2019Sullivan O, Joyce A et al (2013) Divergent metabolic outcomes arising from targeted manipulation of the gut microbiota in diet-induced obesity. Gut 62:220\u2013226. https:\/\/doi.org\/10.1136\/gutjnl-2011-300705","journal-title":"Gut"},{"key":"1193_CR66","doi-asserted-by":"publisher","first-page":"e7125","DOI":"10.1371\/journal.pone.0007125","volume":"4","author":"F Armougom","year":"2009","unstructured":"Armougom F, Henry M, Vialettes B, Raccah D, Raoult D (2009) Monitoring bacterial community of human gut microbiota reveals an increase in Lactobacillus in obese patients and methanogens in anorexic patients. PLoS ONE 4:e7125. https:\/\/doi.org\/10.1371\/journal.pone.0007125","journal-title":"PLoS ONE"},{"key":"1193_CR67","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s11908-012-0301-5","volume":"15","author":"M Million","year":"2013","unstructured":"Million M, Raoult D (2013) The role of the manipulation of the gut microbiota in obesity. Curr Infect Dis Rep 15:25\u201330. https:\/\/doi.org\/10.1007\/s11908-012-0301-5","journal-title":"Curr Infect Dis Rep"},{"key":"1193_CR68","doi-asserted-by":"publisher","first-page":"2388","DOI":"10.3389\/fmicb.2018.02388","volume":"9","author":"C Zhang","year":"2018","unstructured":"Zhang C, Jiao S, Wang ZA, Du Y (2018) Exploring effects of chitosan oligosaccharides on mice gut microbiota in in vitro fermentation and animal model. Front Microbiol 9:2388. https:\/\/doi.org\/10.3389\/fmicb.2018.02388","journal-title":"Front Microbiol"},{"key":"1193_CR69","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.carbpol.2018.02.058","volume":"190","author":"J Zheng","year":"2018","unstructured":"Zheng J, Yuan X, Cheng G, Jiao S, Feng C et al (2018) Chitosan oligosaccharides improve the disturbance in glucose metabolism and reverse the dysbiosis of gut microbiota in diabetic mice. Carbohydr Polym 190:77\u201386. https:\/\/doi.org\/10.1016\/j.carbpol.2018.02.058","journal-title":"Carbohydr Polym"},{"key":"1193_CR70","doi-asserted-by":"publisher","first-page":"2671","DOI":"10.2527\/jas.2011-4699","volume":"90","author":"CM Yang","year":"2012","unstructured":"Yang CM, Ferket PR, Hong QH, Zhou J, Cao GT et al (2012) Effect of chito-oligosaccharide on growth performance, intestinal barrier function, intestinal morphology and cecal microflora in weaned pigs. J Anim Sci 90:2671\u20132676. https:\/\/doi.org\/10.2527\/jas.2011-4699","journal-title":"J Anim Sci"},{"key":"1193_CR71","doi-asserted-by":"publisher","first-page":"4105","DOI":"10.1039\/d0fo01768j","volume":"12","author":"MZ Zhu","year":"2021","unstructured":"Zhu MZ, Zhou F, Ouyang J, Wang QY, Li YL et al (2021) Combined use of epigallocatechin-3-gallate (EGCG) and caffeine in low doses exhibits marked anti-obesity synergy through regulation of gut microbiota and bile acid metabolism. Food Funct 12:4105\u20134116. https:\/\/doi.org\/10.1039\/d0fo01768j","journal-title":"Food Funct"},{"key":"1193_CR72","doi-asserted-by":"publisher","first-page":"34","DOI":"10.3164\/jcbn.18-116","volume":"65","author":"C Ushiroda","year":"2019","unstructured":"Ushiroda C, Naito Y, Takagi T, Uchiyama K, Mizushima K et al (2019) Green tea polyphenol (epigallocatechin-3-gallate) improves gut dysbiosis and serum bile acids dysregulation in high-fat diet-fed mice. J Clin Biochem Nutr 65:34\u201346. https:\/\/doi.org\/10.3164\/jcbn.18-116","journal-title":"J Clin Biochem Nutr"},{"key":"1193_CR73","doi-asserted-by":"publisher","first-page":"fj201800370R","DOI":"10.1096\/fj.201800370R","volume":"32","author":"L Sheng","year":"2018","unstructured":"Sheng L, Jena PK, Liu HX, Hu Y, Nagar N et al (2018) Obesity treatment by epigallocatechin-3-gallate-regulated bile acid signaling and its enriched Akkermansia muciniphila. FASEB J 32:fj201800370R. https:\/\/doi.org\/10.1096\/fj.201800370R","journal-title":"FASEB J"},{"key":"1193_CR74","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1002\/lipd.12131","volume":"54","author":"M Crawford","year":"2019","unstructured":"Crawford M, Whisner C, Al-Nakkash L, Sweazea KL (2019) Six-week high-fat diet alters the gut microbiome and promotes cecal inflammation, endotoxin production, and simple steatosis without obesity in male rats. Lipids 54:119\u2013131. https:\/\/doi.org\/10.1002\/lipd.12131","journal-title":"Lipids"},{"key":"1193_CR75","doi-asserted-by":"publisher","first-page":"594150","DOI":"10.3389\/fimmu.2020.594150","volume":"11","author":"S Mohammad","year":"2020","unstructured":"Mohammad S, Thiemermann C (2020) Role of metabolic endotoxemia in systemic inflammation and potential interventions. Front Immunol 11:594150. https:\/\/doi.org\/10.3389\/fimmu.2020.594150","journal-title":"Front Immunol"},{"key":"1193_CR76","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1007\/s11605-021-05188-7","volume":"26","author":"L An","year":"2022","unstructured":"An L, Wirth U, Koch D, Schirren M, Drefs M et al (2022) The role of gut-derived lipopolysaccharides and the intestinal barrier in fatty liver diseases. J Gastrointest Surg 26:671\u2013683. https:\/\/doi.org\/10.1007\/s11605-021-05188-7","journal-title":"J Gastrointest Surg"},{"key":"1193_CR77","doi-asserted-by":"publisher","first-page":"118750","DOI":"10.1016\/j.lfs.2020.118750","volume":"265","author":"HU Khan","year":"2021","unstructured":"Khan HU, Aamir K, Jusuf PR, Sethi G, Sisinthy SP et al (2021) Lauric acid ameliorates lipopolysaccharide (LPS)-induced liver inflammation by mediating TLR4\/MyD88 pathway in Sprague Dawley (SD) rats. Life Sci 265:118750. https:\/\/doi.org\/10.1016\/j.lfs.2020.118750","journal-title":"Life Sci"}],"container-title":["Journal of Physiology and Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13105-026-01193-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13105-026-01193-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13105-026-01193-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T06:57:48Z","timestamp":1780124268000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13105-026-01193-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,30]]},"references-count":77,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["1193"],"URL":"https:\/\/doi.org\/10.1007\/s13105-026-01193-z","relation":{},"ISSN":["1138-7548","1877-8755"],"issn-type":[{"value":"1138-7548","type":"print"},{"value":"1877-8755","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,30]]},"assertion":[{"value":"3 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Institutional Animal Care and Use Committee of the Faculty of Medicine, Chiang Mai University, in accordance with the National Institutes of Health (NIH) Guidelines, approved the study (Protocol approval number: 07\/2565).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial number"}}],"article-number":"55"}}